#1 Clinical Trials Search in Europe

Risperidone

This article examines the use of risperidone, an antipsychotic medication, in various clinical trials. These studies investigate different formulations of risperidone, including long-acting injectable versions, and assess its safety, efficacy, and impact on patients with schizophrenia and related disorders. The trials explore topics such as bioequivalence, treatment adherence, healthcare utilization, and the development of new delivery methods for this important psychiatric medication.

Table of Contents

What is Risperidone?

Risperidone is an antipsychotic medication used to treat various mental health conditions[1]. It belongs to a class of drugs known as atypical antipsychotics, which work by affecting certain chemicals in the brain to help control symptoms of mental disorders. Risperidone is also known by its brand names, including Risperdal, Risperdal Consta, and Perseris[2][3].

Conditions Treated with Risperidone

Risperidone is primarily used to treat the following conditions:

  • Schizophrenia: A severe mental disorder characterized by distorted thinking, hallucinations, and impaired emotional responsiveness[4].
  • Bipolar disorder: A condition that causes extreme mood swings, including emotional highs (mania) and lows (depression).
  • Autism Spectrum Disorder (ASD): A developmental disorder that affects communication and behavior[5].
  • Cocaine-related disorders: In some cases, risperidone has been studied for its potential in treating cocaine dependence[6].

Forms and Administration of Risperidone

Risperidone is available in several forms to suit different patient needs:

  • Oral tablets: These are taken by mouth, usually once or twice daily[3].
  • Orally disintegrating tablets (ODT): These tablets dissolve quickly in the mouth without needing water, which can be helpful for patients who have difficulty swallowing pills[3].
  • Long-acting injectable (LAI): Also known as Risperdal Consta or Perseris, this form is injected into a muscle every two to four weeks by a healthcare professional[4][2].

The dosage and form of risperidone prescribed will depend on the condition being treated, the severity of symptoms, and individual patient factors. It’s important to take risperidone exactly as prescribed by your doctor.

Effectiveness of Risperidone

Research has shown that risperidone can be effective in managing symptoms of various mental health conditions:

  • Schizophrenia: Studies have demonstrated that risperidone can help reduce symptoms such as hallucinations, delusions, and disorganized thinking. It may also improve social functioning and quality of life for patients with schizophrenia[7].
  • Autism Spectrum Disorder: Risperidone has been found to help manage irritability, aggression, and self-injurious behaviors in some individuals with ASD[5].
  • Bipolar Disorder: The medication can help stabilize mood and reduce manic episodes in people with bipolar disorder.

Effectiveness is often measured using various scales and assessments, such as the Positive and Negative Syndrome Scale (PANSS) for schizophrenia, or the Clinical Global Impression (CGI) scale for overall improvement[4][7].

Side Effects and Safety Considerations

Like all medications, risperidone can cause side effects. Common side effects may include:

  • Weight gain
  • Drowsiness or fatigue
  • Increased appetite
  • Dizziness
  • Constipation
  • Dry mouth
  • Nausea

More serious side effects, though less common, can include:

  • Extrapyramidal symptoms: These are movement disorders that can cause restlessness, muscle stiffness, or involuntary movements[2].
  • Metabolic changes: Risperidone may affect blood sugar levels, cholesterol, and triglycerides.
  • Increased prolactin levels: This can lead to breast enlargement, irregular menstrual cycles in women, or erectile dysfunction in men.
  • Tardive dyskinesia: A potentially irreversible condition causing involuntary movements, particularly of the face and mouth.

It’s crucial to discuss any side effects with your healthcare provider. They can help manage side effects or adjust your treatment if necessary. Regular check-ups and monitoring are important while taking risperidone[2].

Ongoing Research and Clinical Trials

Researchers continue to study risperidone to better understand its effects and explore new potential uses:

  • Comparison with other medications: Studies are comparing risperidone to other antipsychotics, such as aripiprazole, to determine their relative effectiveness and side effect profiles[5].
  • Long-acting injectable formulations: Research is ongoing to develop and improve long-acting injectable forms of risperidone, which could help with medication adherence[2].
  • Effects on oxidative stress: Some studies are investigating how risperidone affects oxidative stress in patients with autism spectrum disorder, which could provide insights into its mechanism of action[5].
  • Use in substance abuse disorders: Researchers are exploring the potential of risperidone in treating substance-related disorders, such as cocaine dependence[6].

These ongoing studies aim to improve our understanding of risperidone and potentially expand its therapeutic uses. As with any medication, it’s important to stay informed about the latest research and discuss any questions or concerns with your healthcare provider.

Aspect Details
Formulations Studied Oral tablets, long-acting injectables (PERSERIS, Risperdal Consta), experimental formulations (ZX003)
Primary Conditions Treated Schizophrenia, Schizoaffective Disorder
Key Outcome Measures PANSS, CGI, GAF, pharmacokinetic parameters, adverse events
Safety Assessments Adverse events, vital signs, laboratory values, extrapyramidal symptoms
Efficacy Assessments Symptom reduction, functional improvement, quality of life
Study Designs Randomized controlled trials, open-label studies, observational studies, bioequivalence studies
Duration of Studies Ranging from short-term (days) to long-term (up to 2 years)
Special Populations Patients with chronic, stable schizophrenia; healthy volunteers for bioequivalence studies

FAQ

  • What is risperidone used to treat? Risperidone is primarily used to treat schizophrenia and schizoaffective disorder. It is an antipsychotic medication that helps manage symptoms such as hallucinations, delusions, and disorganized thinking.
  • What forms of risperidone are being studied in clinical trials? Clinical trials are investigating various forms of risperidone, including oral tablets, long-acting injectable formulations (such as Risperdal Consta and PERSERIS), and new experimental versions like ZX003 (Risperidone-SABER®).
  • How do long-acting injectable forms of risperidone differ from oral tablets? Long-acting injectable forms of risperidone are administered less frequently (e.g., every 2-4 weeks) compared to daily oral tablets. They aim to improve treatment adherence and maintain more consistent drug levels in the body.
  • What is bioequivalence in the context of risperidone studies? Bioequivalence studies compare different formulations of risperidone to ensure they have similar rates and extents of absorption in the body. This helps establish that new formulations or generic versions are as effective as the original brand-name drug.
  • How do clinical trials assess the safety and efficacy of risperidone? Clinical trials assess risperidone's safety by monitoring adverse events, changes in vital signs, laboratory values, and extrapyramidal symptoms. Efficacy is evaluated using scales like the Positive and Negative Syndrome Scale (PANSS), Clinical Global Impression (CGI) scales, and measures of patient functioning and quality of life.

Ongoing Clinical Trials on Risperidone

  • Study on the Effectiveness of Aripiprazole and Paliperidone in Patients Experiencing Their First Episode of Schizophrenia

    Recruiting

    1 1 1 1
    Investigated diseases:
    Investigated drugs:
    Spain

  • Study on the Effects of Vortioxetine on Cognitive Function in Patients with Early Schizophrenia

    Recruiting

    1 1 1 1
    Investigated drugs:
    Spain

  • Study on Personalized Dosing of Sertraline, Aripiprazole, and Risperidone for Patients with Mood, Anxiety, or Psychotic Disorders

    Recruiting

    1 1 1 1
    Investigated diseases:
    Investigated drugs:
    Germany The Netherlands Spain

  • Studying the Safety of Aripiprazole and Risperidone in Children and Adolescents with Autism Spectrum Disorder

    Recruiting

    1 1 1 1
    Investigated diseases:
    Investigated drugs:
    Germany The Netherlands

  • Study on the Effect of Clozapine and Drug Combination for Patients with Schizophrenia Experiencing First-Line Treatment Failure

    Recruiting

    1 1 1 1
    Investigated diseases:
    Investigated drugs:
    Austria Germany Italy Spain

  • Study on Reducing Antipsychotic Dose vs. Maintenance Treatment for Patients with Schizophrenia Using Haloperidol Decanoate, Risperidone, and Amisulpride

    Not yet recruiting

    1 1 1 1
    Investigated drugs:
    France

  • Study on Continuing or Reducing Antipsychotic Medication (Haloperidol, Clozapine, Tiapride) for Patients After First Episode of Psychosis

    Not recruiting

    1 1 1 1
    Investigated diseases:
    Investigated drugs:
    The Netherlands

  • Study of Cannabidiol and Risperidone for Treatment of Non-Affective Psychosis in Patients with History of Cannabis Use

    Not recruiting

    1 1 1
    Investigated diseases:
    Investigated drugs:
    Denmark

Glossary

  • Schizophrenia: A serious mental disorder characterized by distortions in thinking, perception, emotions, language, sense of self and behavior.
  • Schizoaffective Disorder: A mental health condition that includes features of both schizophrenia and mood disorders, such as depression or bipolar disorder.
  • Antipsychotic: A type of medication used to treat psychosis, including delusions, hallucinations, paranoia, or disordered thought, particularly in schizophrenia and bipolar disorder.
  • Bioequivalence: The property of two drug products having the same rate and extent of absorption, making their effect essentially the same.
  • Pharmacokinetics (PK): The study of how a drug moves through the body, including its absorption, distribution, metabolism, and excretion.
  • Long-acting injectable (LAI): A form of medication that is injected and releases the active drug slowly over an extended period, typically weeks or months.
  • PERSERIS: A brand name for a long-acting injectable form of risperidone administered subcutaneously once monthly.
  • Risperdal Consta: A brand name for a long-acting injectable form of risperidone administered intramuscularly every two weeks.
  • Extrapyramidal symptoms (EPS): Movement disorders that can occur as side effects of antipsychotic medications, including tremors, muscle stiffness, and involuntary movements.
  • Positive and Negative Syndrome Scale (PANSS): A medical scale used to measure symptom severity in patients with schizophrenia.
  • Clinical Global Impression (CGI): A scale used to assess the overall severity of a patient's mental illness and changes in their condition over time.
  • Global Assessment of Functioning (GAF): A scale used to rate how well a person is functioning in their daily life across psychological, social, and occupational domains.

References

  1. https://clinicaltrials.gov/study/NCT00294008
  2. https://clinicaltrials.gov/study/NCT03978832
  3. https://clinicaltrials.gov/study/NCT02012049
  4. https://clinicaltrials.gov/study/NCT00589914
  5. https://clinicaltrials.gov/study/NCT05868720
  6. https://clinicaltrials.gov/study/NCT00000317
  7. https://clinicaltrials.gov/study/NCT00246194